The EU has taken on board the G20 commitments and recommendations on reforming the derivatives market. EMIR' (the European Market Infrastructure Regulation) is the central pillar of this wide ranging program of regulatory reform. It builds a new regulatory framework where market participants have to play and define a new set of rules to comply with. EMIR is significantly shaping the derivatives' world and affects risk management, counterparty risk - including central counterparties - clearing, collateralisation and reporting.
EMIR introduces a number of complex issues and creates challenges and risks on one side and opportunities on the other side for all market participants, mainly banks, asset managers and other financial services firms, i.e. custody and financial advisors.
During this highly practical 1 day course you will have a chance to learn about the key elements of the new regulation as well as opportunities and challenges that come with it. You will also be able to identify the relevant issues for your organisation and how EMIR can impact your business
Topics Covered During This Training
- Why EMIR?
- Addressing the interconnectedness in OTC derivatives markets
- EMIR and other key regulatory developments: Basel III / CRD IV, Dodd-Frank and MIFID
- ESMA - European Securities and Markets Authority
- EMIR objectives and implementation timeline
- Subject matter, scope and definitions
- Clearing, reporting and risk mitigation of OTC derivatives
- Key challenges: valuation (mark-to-market, mark-to-model, collateralisation)
- Risk management procedures
- Authorisation of Central Counterparties (CCPs)
- Other provisions
- Key challenges, opportunities and risks for asset managers, securities services, banks and financial advisors
By the end of this course you will:
- Understand the background to EMIR and the regulation's key elements
- Be able to place EMIR in the context of other major regulations including Basel III, Dodd-Frank and MIFID
- Explore the implications for clearing, reporting and risk mitigation of OTC derivatives
- Become aware of challenges and opportunities
- Identify the right risk management procedures
- Assess the impact of EMIR for your organisation/business
For more information about this conference visit http://www.researchandmarkets.com/research/7mg4sp/european_market